ArticleJournal of clinical medicine2022

Editorial: Apatinib and Anlotinib in the Treatment of Radioactive Iodine Refractory and Highly Invasive Thyroid Carcinoma.

Wenqing Jia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.